Fig. 1From: Alemtuzumab for multiple sclerosis: the new concept of immunomodulationCD52 is a short peptide of 12 amino acids highly expressed on T and B lymphocytes, and at very low levels on natural killer cells (NK), monocytes and macrophages (Mo), while neutrophils (N), dendritic cells (DC) and bone marrow stem cells (SC) do not express this moleculeBack to article page